Raleigh, NC, United States of America

Clark Zervos



 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Inventor Clark Zervos: A Pioneer in Blood Antibody Identification**

Introduction

Clark Zervos, an innovative inventor based in Raleigh, NC, has made significant contributions to the field of blood product safety through his groundbreaking work. With a focus on identifying atypical antibodies, Zervos's inventions aim to enhance the quality control processes in blood manufacturing.

Latest Patents

Zervos holds a patent for a method that identifies atypical antibodies in human blood and blood products. This invention is crucial as it addresses potential false positives in quality control testing during the manufacturing processes of intermediate or final blood products. The patent underscores Zervos's commitment to improving the safety and efficacy of blood transfusions.

Career Highlights

Clark Zervos works for Grifols, S.A., a global leader in the biopharmaceutical industry that specializes in the development of life-saving medicines from human plasma. His role within the company involves leveraging his expertise in immunology to enhance blood product safety, ensuring that high standards are maintained in the manufacturing processes.

Collaborations

In his professional journey, Zervos collaborates closely with his coworker, Joann Hotta, contributing to advancements in blood safety and product quality. Together, they work on research and development initiatives that strive to improve diagnostic methods and manufacturing processes.

Conclusion

Clark Zervos's innovative work in the realm of blood antibody identification marks him as a notable figure in his field. His patented method not only reflects his dedication to scientific advancement but also showcases the importance of ensuring safety in blood transfusion practices. With ongoing collaborations and a strong foundation in his company, Zervos continues to influence the future of blood product manufacturing.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…